As with bradycardia pacing, a number of recognized complications may arise. A recent systematic review of CRT trials found failure to successfully place the LV lead in 7% of implants, procedural ...

AF compromises CRT delivery due to RR interval variability and competing tachycardia, and may even result in excessive rapid ventricular pacing during atrial tracking. Atrial arrhythmias represent ...

The global MRI-safe Cardiac Resynchronization Therapy (CRT) devices market is poised for significant growth, with an expected ...

The medical sector is rapidly evolving as new technologies and scientific breakthroughs challenge traditional standards of ...

Primary prevention implantable cardioverter-defibrillators (ICDs) equipped for antitachycardia pacing (ATP) offered fewer ...

India Pacemaker Market is flourishing due to the rising prevalence of cardiovascular diseases, growing geriatric population, increasing life expectancy, and government’s supportive reimbursement ...

THE NHS fits 18,000 pacemakers a year. Here, 67-year-old Joyce Underwood, who lives with her husband in Kibworth, near Leicester, tells us about her operation, and her cardiologist explains the ...

Company anticipates US FDA approval in Q1 CY25 comprising for WiSE, which is the first pacing system within the ... the commercialisation of its WiSE CRT system in anticipation of US FDA approval ...

Objective Most patients who have an implantable cardioverter-defibrillator (ICD) implant do not receive life-prolonging therapy from it. Little research has been undertaken to determine which patients ...

EBR is undertaking a fully underwritten institutional placement and entitlement offer to raise $50m ahead of anticipated US FDA approval for its WiSE CRT system ... is the first pacing system ...